vs
Liberty Broadband Corp(LBRDA)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
Liberty Broadband Corp的季度营收约是REPLIGEN CORP的1.3倍($261.0M vs $197.9M),Liberty Broadband Corp净利率更高(146.7% vs 6.7%,领先140.0%),REPLIGEN CORP同比增速更快(13.6% vs 6.1%),Liberty Broadband Corp自由现金流更多($37.0M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 4.3%)
本公司是一家覆盖英、荷、美三地的跨国电信企业,注册地为百慕大,在伦敦、阿姆斯特丹、丹佛设有总部,旗下拥有多家对应司法辖区的运营主体,其中英国主体为公开上市实体,2005年由自由媒体国际业务板块与UnitedGlobalCom合并成立。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
LBRDA vs RGEN — 直观对比
营收规模更大
LBRDA
是对方的1.3倍
$197.9M
营收增速更快
RGEN
高出7.5%
6.1%
净利率更高
LBRDA
高出140.0%
6.7%
自由现金流更多
LBRDA
多$19.4M
$17.6M
两年增速更快
RGEN
近两年复合增速
4.3%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $261.0M | $197.9M |
| 净利润 | $383.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 15.7% | 9.0% |
| 净利率 | 146.7% | 6.7% |
| 营收同比 | 6.1% | 13.6% |
| 净利润同比 | 96.4% | 143.9% |
| 每股收益(稀释后) | $2.68 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LBRDA
RGEN
| Q4 25 | — | $197.9M | ||
| Q3 25 | — | $188.8M | ||
| Q2 25 | $261.0M | $182.4M | ||
| Q1 25 | $266.0M | $169.2M | ||
| Q4 24 | $263.0M | $174.1M | ||
| Q3 24 | $262.0M | $154.9M | ||
| Q2 24 | $246.0M | $154.1M | ||
| Q1 24 | $245.0M | $151.3M |
净利润
LBRDA
RGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | — | $14.9M | ||
| Q2 25 | $383.0M | $14.9M | ||
| Q1 25 | $268.0M | $5.8M | ||
| Q4 24 | $291.0M | $-30.3M | ||
| Q3 24 | $142.0M | $-654.0K | ||
| Q2 24 | $195.0M | $3.3M | ||
| Q1 24 | $241.0M | $2.1M |
毛利率
LBRDA
RGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率
LBRDA
RGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | 15.7% | 7.6% | ||
| Q1 25 | 16.2% | 3.9% | ||
| Q4 24 | 4.9% | -17.7% | ||
| Q3 24 | 11.5% | -5.1% | ||
| Q2 24 | 8.5% | 1.0% | ||
| Q1 24 | 11.4% | 1.3% |
净利率
LBRDA
RGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | 146.7% | 8.2% | ||
| Q1 25 | 100.8% | 3.4% | ||
| Q4 24 | 110.6% | -17.4% | ||
| Q3 24 | 54.2% | -0.4% | ||
| Q2 24 | 79.3% | 2.2% | ||
| Q1 24 | 98.4% | 1.4% |
每股收益(稀释后)
LBRDA
RGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | $2.68 | $0.26 | ||
| Q1 25 | $1.87 | $0.10 | ||
| Q4 24 | $2.04 | $-0.55 | ||
| Q3 24 | $0.99 | $-0.01 | ||
| Q2 24 | $1.36 | $0.06 | ||
| Q1 24 | $1.69 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $767.6M |
| 总债务越低越好 | $3.1B | $542.2M |
| 股东权益账面价值 | $10.4B | $2.1B |
| 总资产 | $16.6B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
LBRDA
RGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | $180.0M | $708.9M | ||
| Q1 25 | $226.0M | $697.2M | ||
| Q4 24 | $163.0M | $757.4M | ||
| Q3 24 | $168.0M | $784.0M | ||
| Q2 24 | $73.0M | $809.1M | ||
| Q1 24 | $108.0M | $780.6M |
总债务
LBRDA
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.8B | — | ||
| Q4 24 | $3.8B | $525.6M | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.6B | — |
股东权益
LBRDA
RGEN
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | $10.4B | $2.1B | ||
| Q1 25 | $10.1B | $2.0B | ||
| Q4 24 | $9.8B | $2.0B | ||
| Q3 24 | $9.5B | $2.0B | ||
| Q2 24 | $9.3B | $2.0B | ||
| Q1 24 | $9.1B | $2.0B |
总资产
LBRDA
RGEN
| Q4 25 | — | $2.9B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | $16.6B | $2.9B | ||
| Q1 25 | $17.0B | $2.9B | ||
| Q4 24 | $16.7B | $2.8B | ||
| Q3 24 | $16.3B | $2.8B | ||
| Q2 24 | $16.0B | $2.9B | ||
| Q1 24 | $15.7B | $2.8B |
负债/权益比
LBRDA
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.38× | — | ||
| Q4 24 | 0.38× | 0.27× | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $91.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $37.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 14.2% | 8.9% |
| 资本支出强度资本支出/营收 | 20.7% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.24× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-49.0M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
LBRDA
RGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | — | $48.1M | ||
| Q2 25 | $91.0M | $28.6M | ||
| Q1 25 | $78.0M | $15.0M | ||
| Q4 24 | $1.0M | $39.2M | ||
| Q3 24 | $24.0M | $49.3M | ||
| Q2 24 | $27.0M | $42.2M | ||
| Q1 24 | $52.0M | $44.7M |
自由现金流
LBRDA
RGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | $37.0M | $21.5M | ||
| Q1 25 | $13.0M | $11.4M | ||
| Q4 24 | $-63.0M | $33.6M | ||
| Q3 24 | $-36.0M | $42.3M | ||
| Q2 24 | $-35.0M | $37.4M | ||
| Q1 24 | $-9.0M | $36.4M |
自由现金流率
LBRDA
RGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | 14.2% | 11.8% | ||
| Q1 25 | 4.9% | 6.8% | ||
| Q4 24 | -24.0% | 19.3% | ||
| Q3 24 | -13.7% | 27.3% | ||
| Q2 24 | -14.2% | 24.3% | ||
| Q1 24 | -3.7% | 24.0% |
资本支出强度
LBRDA
RGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | 20.7% | 3.9% | ||
| Q1 25 | 24.4% | 2.1% | ||
| Q4 24 | 24.3% | 3.2% | ||
| Q3 24 | 22.9% | 4.5% | ||
| Q2 24 | 25.2% | 3.1% | ||
| Q1 24 | 24.9% | 5.5% |
现金转化率
LBRDA
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 0.24× | 1.92× | ||
| Q1 25 | 0.29× | 2.57× | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.17× | — | ||
| Q2 24 | 0.14× | 12.70× | ||
| Q1 24 | 0.22× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图